Company Filing History:
Years Active: 1997
Title: Michele Tardieu: Innovator in Cell and Tissue Regeneration
Introduction
Michele Tardieu is a notable inventor based in Champigny sur Marne, France. He has made significant contributions to the field of regenerative medicine, particularly through his innovative methods for cell and tissue regeneration.
Latest Patents
Michele Tardieu holds a patent for a method of regenerating cells and tissues using functionalized dextrans. This patent, which is titled "Method of regenerating cells and tissues using functionalized dextrans," describes compositions that are useful for regenerating cells and tissues. The compositions comprise at least one functionalized dextran that has been substituted with carboxymethyl, benzylamide, or benzylamide sulfonate. These dextrans can be utilized alone or in combination with acid or basic fibroblast growth factors to enhance tissue or cell regeneration. Additionally, these dextrans improve the stability of acid or basic fibroblast growth factors.
Career Highlights
Michele Tardieu is associated with Therapeutiques Substitutives, where he applies his expertise in regenerative medicine. His work focuses on developing innovative solutions that can significantly impact the field of tissue engineering and regenerative therapies.
Collaborations
Michele has collaborated with notable colleagues in his field, including Denis S Barritault and Jacqueline Jozefonvicz. These collaborations have contributed to advancing research and development in regenerative medicine.
Conclusion
Michele Tardieu is a pioneering inventor whose work in cell and tissue regeneration has the potential to transform medical treatments. His innovative approaches and collaborations continue to push the boundaries of regenerative medicine.